ctDNA from body fluids is an adequate source for <i>EGFR</i> biomarker testing in advanced lung adenocarcinoma

202117 citationsJournal Articlehybrid Open Access

Authors

ctDNA derived from body fluids is an informative source for <i>EGFR</i> biomarker testing, with greater sensitivity than plasma samples.

Good health and well-being

Published in: Clinical Chemistry and Laboratory Medicine (CCLM)

Volume 59, Issue 7, pp. 1221-1229

Field-Weighted Citation Impact: 0.79